Breast Cancer Survival Defined by the ER/PR/HER2 Subtypes and a Surrogate Classification according to Tumor Grade and Immunohistochemical Biomarkers.Parise CA, Caggiano V.J Cancer Epidemiol. 2014;2014:469251. doi: 10.1155/2014/469251. Epub 2014 May 26, Breast Journal, 2014 May 26
Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial
Ann Fam Med. 2014 May-Jun;12(3):204-14. doi: 10.1370/afm.1623.Sociopsychological tailoring to address colorectal cancer screening disparities: a randomized controlled trial.
2014 May 30
Disparities in receipt of adjuvant radiation therapy after breast-conserving surgery among the cancer-reporting regions of California.
2011 Sep 14
Breast Cancer Subtypes as Defined by the Estrogen Receptor (ER), Progesterone Receptor (PR), and the Human Epidermal Growth Factor Receptor 2 (HER2) among Women with Invasive Breast Cancer in California
2009 Dec 20
J Oncol Pract. 7(3 Suppl):e1s-7s. doi: 10.1200/JOP.2011.000299
2011 May 01
Tradeoffs of using administrative claims and medical records to identify the use of personalized medicine for patients with breast cancer.
Med Care. 49(6):e1-8. doi: 10.1097/MLR.0b013e318207e87e.
2011 Jun 01